Basit öğe kaydını göster

dc.contributor.authorEngin CD,Ekinci UB,Selver A,Saatçi AO
dc.date.accessioned2023-03-02T11:25:39Z
dc.date.available2023-03-02T11:25:39Z
dc.date.issued2020
dc.identifier.urihttp://hdl.handle.net/20.500.12481/16264
dc.description.abstractThe aim of this study was to report the outcome of topical brinzolamide 1% treatment on macular cystoid lesions resembling retinoschisis in 4 patients diagnosed with posterior microphthalmia. The medical records of 4 patients with a clinical diagnosis of posterior microphthalmia who had started topical brinzolamide 1% treatment were reviewed. Visual acuity, central foveal thickness, and cystoid lesion area percentage were used to evaluate treatment response. In the follow-up, there was a decrease in central foveal thicknesses and cystoid lesion area percentages in both eyes of 3 of the patients. However, 1 patient showed increases in both parameters. Visual acuity remained stable in 5 eyes and increased in 3 eyes. Topical brinzolamide treatment may have some positive effects on macular cystoid lesions in selected cases. © 2020 by Turkish Ophthalmological Association Turkish Journal of Ophthalmology, published by Galenos Publishing House.
dc.titleEfficacy of topical brinzolamide treatment in posterior microphthalmos-related macular cystoid lesions: A case series
dc.identifier.DOI-ID10.4274/tjo.galenos.2019.40504
dc.identifier.volume50
dc.identifier.issue1
dc.identifier.startpage44
dc.identifier.endpage49
dc.identifier.issn/e-issn2149-8709


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

  • Scopus [2994]
    Scopus İndeksli Yayınlar Koleksiyonu

Basit öğe kaydını göster